Diego Albani graduated in biological sciences in 1996 with full marks, and he has been working at Mario Negri Institute since 2002, after a 3-year postdoctoral experience in the laboratory of Professor Renato Dulbecco, CNR-ITBA, Milan, Italy. He has been the Head of the Unit of Genetics of Neurodegenerative Disorders since 2011. His present interests deal with the biological basis of neurodegenerative disorders including Alzheimer’s (AD) and Parkinson’s disease (PD), with a particular focus on genetics, oxidative stress, and recombinant proteins as innovative drugs. Dr. Albani is actively involved in ongoing research projects focused on pharmacogenomics of AD, the genetic basis of aging, and the activation of neuronal enzymes (sirtuins) by natural phytoproducts as novel strategy against AD and PD. He is currently a member of the editorial boards of three international journals.
Biography Updated on 1 February 2012